Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sucralfate + metronidazole + lidocaine
- Development stage
- Unknown
- Lead developer
- Gopal Lifesciences
- Modality
- Small Molecules
- Administration
- Topical, Rectal
01
Overview
Proctocalm is a topical combination cream containing sucralfate, metronidazole, and lidocaine (lignocaine) hydrochloride, developed and manufactured by Gopal Lifesciences. It is indicated for the local treatment and symptomatic relief of painful anorectal conditions, including anal fissures, hemorrhoids (piles), fistulas, and post-operative anorectal wounds. Within the formulation, lidocaine acts as a local anesthetic to provide rapid pain relief by blocking voltage-gated sodium channels. Metronidazole serves as an antibacterial agent targeting anaerobic bacteria to prevent local infections and reduce inflammation. Sucralfate acts as a cytoprotective agent, forming a physical barrier over damaged mucosal tissue to shield it from irritation and promote wound healing.
- Brand names
- Proctocalm
- Other names
- sucralfate + metronidazole + lidocaine hydrochloridesucralfate + metronidazole + lignocainesucralfate + metronidazole + lignocaine hydrochloride
02
Targets
NeuraminidaseFGF2MUC2 (Mucin-2)PEP (Pepsin)DNANaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on sucralfate + metronidazole + lidocaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sucralfate + metronidazole + lidocaine.